Join us for a focused webinar exploring the latest developments in brain cancer research and treatment, presented at one of the most influential oncology conferences — the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting.
Hosted by the COGNO Outreach and Education Committee, this session will highlight the most impactful updates with a focus on clinical relevance and research trends. Our expert panel discussion will explore how the new international data impacts patient care at home.
Chair & Speaker
Medical Oncologist, VIC
Jim Whittle is Neuro Oncologist at the Peter MacCallum Cancer Centre (PeterMac) and joint-head of the Brain Cancer Research Laboratory at WEHI. Jim’s research expertise and reputation are built on a deep understanding of basic biology, the development of patient-derived models for drug discovery, and clinical translation. His clinical research focuses on implementing novel Phase 0 (Perioperative) clinical trials as part of a paradigm shift in drug development.
An emerging leader in the field of Neuro Oncology, Jim has an established institutional and national profile, currently serving on the management committee and chairing the Outreach and Education Committee for the Cooperative Group for Neuro Oncology (COGNO), as well as participating in various committees within the Society of Neuro Oncology (SNO). In 2023, Jim was appointed Co-Director of Research Strategy at the Brain Cancer Centre (Melbourne) and sits on the research advisory committee for the Mark Hughes Foundation Centre for Brain Cancer Research.
Speaker
Medical Oncologist, NSW
Dr Tam Bui is a staff specialist medical oncologist and the Medical Director of the Medical Oncology Clinical Trials Unit at the Concord Cancer Centre. She sub-specialises in neuro-oncology, upper gastrointestinal and breast cancers.
She completed her PhD through the University of Sydney on the topic of, 'Scanxiety: scan-associated anxiety in people with advanced cancers' in 2023. She is interested in improving outcomes of her patients with cancer through a considered, holistic approach towards the efficacy, safety and psychosocial impacts of cancer treatment.
Speaker
Medical Oncologist, NSW
Dr. Udit Nindra completed his medical training at the University of New South Wales with Honours in 2016. Following completion of core medical oncology training, he completed a dedicated fellowship at Liverpool Hospital focusing on early phase clinical trials in 2023 before joining the Illawarra Shoalhaven Local Health District as a staff specialist consultant in medical oncology in January 2024.
He currently leads the early phase (phase 1) clinical trials service through the Illawarra. He also recently joined the Liverpool Hospital Medical Oncology Team as a dedicated clinical trials and theranostics consultant in February 2025. Dr Nindra has a keen interest in head & neck and brain tumours with a strong focus on clinical trial access for regional and rural patients.
Education Events
Education Events
Education Events
